T2	Gene_or_gene_product 45 79	vascular endothelial growth factor
T3	Drug_or_compound 80 91	bevacizumab
T4	Drug_or_compound 93 100	Avastin
T5	Drug_or_compound 126 137	bevacizumab
T6	Tissue 188 194	macula
T8	Tissue 286 295	capillary
T10	Drug_or_compound 433 444	bevacizumab
T12	Drug_or_compound 713 724	Bevacizumab
T15	Drug_or_compound 1118 1129	bevacizumab
T16	Drug_or_compound 1192 1203	bevacizumab
T17	Multi-tissue_structure 1302 1310	vascular
T18	Gene_or_gene_product 1363 1397	vascular endothelial growth factor
T1000	Organism 229 237	patients
T1001	Organism 514 521	patient
T1002	Organism 868 876	patients
T1003	Organism 1038 1046	patients
T1	Gene_or_gene_product 40 79	anti-vascular endothelial growth factor
T19	Gene_or_gene_product 1358 1397	anti-vascular endothelial growth factor
T14	Pathological_formation 266 271	edema
T22	Pathological_formation 800 805	edema
T23	Tissue 1418 1424	tissue
T9	Blood_vessel_development 309 327	neovascularization
*	Equiv T3 T4
T11	Planned_process 138 147	treatment
E1	Planned_process:T11 Instrument:T5
T13	Regulation 174 183	affecting
E2	Regulation:T13 Cause:E1 Theme:T6
T20	Planned_process 407 429	intravitreal injection
E3	Planned_process:T20 Instrument:T10
T21	Planned_process 725 734	treatment
E4	Planned_process:T21 Instrument:T12
T24	Breakdown 1425 1431	damage
E5	Breakdown:T24 Theme:T23
T25	Negative_regulation 1411 1417	reduce
E6	Negative_regulation:T25 Theme:E5
E8	Blood_vessel_development:T9 
